Funded Tech Companies

ProLynx

Based in San Francisco, ProLynx has funding from OrbiMed, 5AM Ventures and Monograph Capital.

Company Overview

Company Name
ProLynx
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
135 Mississippi Street
San Francisco, CA 94107
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Prolynx is a biotechnology company dedicated to developing ultra-long-acting medicines for obesity and related metabolic diseases. The company's proprietary portfolio is built on a proven half-life extension technology engineered to support more consistent, long-term treatment with improved tolerability and optimized pharmacokinetics.
Profile
ProLynx LinkedIn Company Profile
Social Media
ProLynx Company Twitter Account
Company News
ProLynx News
Facebook
ProLynx on Facebook
YouTube
ProLynx on YouTube
Last Transaction
12/11/2025

Financing History

Date
Type
Amount
Venture Equity
$70,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Chris Boulton
  Chris Boulton LinkedIn Profile  Chris Boulton Twitter Account  Chris Boulton News  Chris Boulton on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Prolucent Health | Promamec

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary